Article Versions Notes

Hughes DA, Deegan P, Giraldo P, Göker-Alpan Ö, Lau H, Lukina E, Revel-Vilk S, Scarpa M, Botha J, Gadir N, et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). Journal of Clinical Medicine. 2022; 11(17):5158. https://doi.org/10.3390/jcm11175158

Hughes, Derralynn A., Patrick Deegan, Pilar Giraldo, Özlem Göker-Alpan, Heather Lau, Elena Lukina, Shoshana Revel-Vilk, Maurizio Scarpa, Jaco Botha, Noga Gadir, and et al. 2022. "Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)" Journal of Clinical Medicine 11, no. 17: 5158. https://doi.org/10.3390/jcm11175158

Hughes, D. A., Deegan, P., Giraldo, P., Göker-Alpan, Ö., Lau, H., Lukina, E., Revel-Vilk, S., Scarpa, M., Botha, J., Gadir, N., & Zimran, A., on behalf of the GOS Steering Committee. (2022). Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). Journal of Clinical Medicine, 11(17), 5158. https://doi.org/10.3390/jcm11175158